Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)
Clinical trial NCT04550962 · COMPLETED
Trial details
- NCT number
- NCT04550962
- Sponsor
- Sanofi
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-11-02
- Primary completion
- 2026-06-18
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.